OUTCOMES OF TRAINING GENERAL PRACTITIONERS TO PRESCRIBE METHADONE

Similar documents
Clinical Guidelines and Procedures for the Use of Naltrexone in the Management of Opioid Dependence Abbreviated Version

What is harm reduction?

The National Methamphetamine Symposium:

ROYAL COLLEGE OF PSYCHIATRISTS RAPID EVIDENCE REVIEW OF EVIDENCE-BASED TREATMENT FOR GAMBLING DISORDER IN BRITAIN

Minister s Opioid Emergency Response Commission Recommendations to the Minister Updated July 5, 2018

Public Policy Statement on the Regulation of Office-Based Opioid Treatment

Submission to. MBS Review Taskforce Eating Disorders Working Group

22 April 2002 Central Australian Aboriginal Congress Submission: Taskforce on Illicit Drugs

Pharmacotherapy. Position Paper: Pharmacotherapy. Introduction. Victorian Alcohol and Drug Association (VAADA) Issued August 2011

1. Establish a baseline of current activities to facilitate future evaluation of consumer participation in each hospital.

THE DEMAND FOR METHADONE MAINTENANCE TREATMENT IN AUSTRALIA

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity

Catriona Matheson, Christine M. Bond, Michela Tinelli. Introduction

Primary Health Networks

Primary Health Networks Drug and Alcohol Treatment Services Funding. Updated Activity Work Plan : Drug and Alcohol Treatment

Core Competencies Clinical Psychology A Guide

Drug related hospital stays in Australia

Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017

Asthma & Victorian Schools Model Policy

National Guidelines. Interim methadone prescribing

PCC4U. Uptake of the PCC4U Resources. Funded by the Australian Government through the National Palliative Care Program

Drug Misuse and Dependence Guidelines on Clinical Management

The Opioid Crisis: What Can Physicians Do About It?

Asthma Policy. Policy Development and Management. Policy No: 17. Date of First Issue: August Last Review Date: August 2017

Addiction Therapy-2014

Matching GP terms to the ICD-10-AM index

COVER SHEET. Accessed from Copyright 2003 Australasian Medical Publishing Company

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

1.0 BACKGROUND INFORMATION

April 2019 NATIONAL POLICY PLATFORM

Primary Health Networks

Eye health promotion by optometrists in rural Victoria

Prescribing drugs of dependence

S 0332 S T A T E O F R H O D E I S L A N D

Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction

DUMFRIES AND GALLOWAY ALCOHOL AND DRUG PARTNERSHIP; PRIORITY ACTIONS AND

Interstate dispensing : A case for uniform, intuitive legislation

Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

Primary Health Networks

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

DEPARTMENT OF EDUCATION WESTERN AUSTRALIA JOB DESCRIPTION FORM THIS POSITION REPORTING RELATIONSHIPS

Hospitals Role in Addressing the Opioid Crisis

Real-time prescription monitoring system in Victoria

Public Health Association of Australia: Policy-at-a-glance Pharmaceutical Drug Misuse Policy

Re: Response to discussion points raised at Allied Health Professions Australia (AHPA) Board meeting 20 June 2013 with regard to HWA

NORTH GEELONG SECONDARY COLLEGE ASTHMA POLICY

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Public Health Association of Australia: Policy-at-a-glance Pharmaceutical Drug Misuse Policy

Opiate Dependency bka Opioid Addiction

Buprenorphine versus methadone maintenance: a cost-effectiveness analysis Doran C M, Shanahan M, Mattick R P, Ali R, White J, Bell J

Changes to Australian Government Hearing Services Program and Voucher scheme

POLICY POSITION. Access to Hepatitis C Treatments

Taking the Common Approach to Improve Child Wellbeing. Webinar Presentation July

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

Appendix 1: Data elements included in the AODTS NMDS for

Drugs and Alcohol Abuse Policy

RESEARCH INTRODUCTION. Addiction Centre, Institute of Psychiatry, London SE5 8BB, UK 2 School of Population Health,

Key points within the SPAG2, relevant to an asthma management policy, specify that schools must:

Workplace Drug and Alcohol Policy

The Australian BreastScreen workforce: a snapshot

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Methadone and buprenorphine for the management of opioid dependence

Primary Care Services for blood borne viral hepatitis prevention, treatment and care

Review of Controlled Drugs and Substances Act

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Creating Balance 2017 ATSA Conference Friday October 27 3:30 PM 5:00 PM

Requirements for Nurse Practitioners to Prescribe Buprenorphine-Naloxone (Suboxone):

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

PROGRAMME INITIATION DOCUMENT MENTAL HEALTH PROGRAMME

Prescription drug abuse A timely update

Primary Health Networks

THE CLIMATE IS CHANGING STUDY WITH US FHBHRU. Flinders Human Behaviour and Health Research Unit

The Use of Complementary and Alternative Medicine in Australia Charlie Changli Xue, Lin Zhang, Vivian Lin and David F. Story

Primary Health Networks

THE RESPONSIBLE PHARMACIST REGULATIONS

Updated Activity Work Plan : Drug and Alcohol Treatment NEPEAN BLUE MOUNTAINS PHN

Recognition of Skills and Training Q. Does the Greens support direct referrals to selected medical specialist services?

PHYSIOTHERAPY AND DIABETES

Identifying Problem Gamblers in Gambling Venues

Primary Health Networks

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Professional Doctorate in Counselling Psychology

2018 ALCOHOL POLICY SCORECARD

Oral health trends among adult public dental patients

Position Description. Counsellor, Butterfly National Helpline 1800 ED HOPE

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007

Ecstasy and Related Drugs Reporting System drug trends bulletin April 2014

Workplace Drug and Alcohol Policy

FHBHRU. Flinders Human Behaviour and Health Research Unit. Study with Us

Position is based Access Health & Community: Hawthorn and Doncaster East Manager, Alcohol and Other Drug Service

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

A reduction in the availability of heroin in Australia

Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)

Brief workshops to teach drug and alcohol first aid: A pilot evaluation study

AGE OF INITIATION TO HEROIN USE: COHORT TRENDS AND CONSEQUENCES OF EARLY INITIATION FOR SUBSEQUENT ADJUSTMENT. Michael Lynskey & Wayne Hall

Drug-related hospital stays in Australia

Etat des lieux des traitements méthadone et buprénorphine. A/Prof Adrian Dunlop Biarritz 2015

SUPERVISION OF RADIOLOGY TRAINEES IN TRAINING DEPARTMENTS GUIDELINES

Family Violence Integration Project. Eastern Community Legal Centre

Transcription:

LIBBY HOTHAM, ANN M ROCHE, EMMA FITZGERALD OUTCOMES OF TRAINING GENERAL PRACTITIONERS TO PRESCRIBE METHADONE LIBBY HOTHAM, ANN M ROCHE, EMMA FITZGERALD Over the last decade, most jurisdictions throughout Australia have increased treatment options for opioid dependent clients by extending methadone prescribing rights to General Practitioners (GPs). Registration to prescribe methadone is achieved after short, intensive training programs. These programs have been developed after interjurisdictional consultation and now also encompass other pharmacotherapies for opioid dependence. However, it is recognised that many GPs who undergo methadone training do not go on to become methadone prescribers. This is of concern on two counts. Firstly, because it is a waste of training resources and, secondly, because there is an acknowledged shortfall in methadone provision in Australia. Current research at the National Centre for Education and Training on Addiction (NCETA) aims to examine factors that influence GPs decision to undertake methadone training, prescribe methadone after training and continue to engage with methadone clients. Issues such as post-training support and factors inhibiting uptake of training, engagement in methadone prescribing, and maintenance of activity in the area will be canvassed. The research is being conducted over four jurisdictions (South Australia, Queensland, New South Wales and Victoria). 3 BACKGROUND Libby Hotham Lecturer Ann M Roche Director Emma Fitzgerald Lecturer National Centre for Education and Training on Addiction (NCETA) Flinders University Since its first use in the United States in the 1960 s (Dole and Nyswander, 1965), evidence for the efficacy of methadone as a treatment for opioid dependence has increased. Despite the emergence of newer pharmacotherapies, methadone is still regarded as the gold standard for the treatment of opioid dependence (Mattick, Ali, Diguisto, Bammer et al, 2001). However, methadone treatment continues to attract criticism. Some believe it is inappropriate to give a drug to addicted people, particularly an agonist drug such as methadone (Watters, 1999). Sections of the popular media have sometimes vehemently joined in this criticism (Bell, 2002). Over the last decade, most jurisdictions throughout Australia have increased the availability of treatment for opioid dependent clients by extending methadone prescribing rights to General Practitioners (GPs). 93

Outcomes of Training General Practitioners to Prescribe Methadone This move into the private sector was partly prompted by the need to reduce waiting lists for public clinic services. However, a philosophical shift was also occurring with an increased commitment to community based care. GP care was seen to provide clients with treatment in a normalised setting, while simultaneously giving them increased access to other health services. The Australian experience mirrors that of the United Kingdom, where a community based model of care has been operating since the 1980s (Glanz, 1993). These arrangements contrast with those of the United States where methadone provision has only ever been through publicly funded programs. Officebased provision, as it has been termed, has been restricted to clinical trial situations (Fiellin et al, 2001). In Australia, prescribing of methadone by GPs was first undertaken in New South Wales and Victoria, without any formal training for prescribers. The inherent risk in methadone treatment (Wodak and Bell, 1996), particularly during the induction period (Humeniuk, Ali, White, Hall and Farrell, 2000), resulted in the introduction of pre-prescribing training for GPs. Training and extension of methadone provision in other states were instigated concurrently. Training is state based, although increasingly there has been interjurisdictional collaboration on the content of training courses (Allsop et al, 1997). Programs generally involve short, intensive, face-to-face training followed by supervised clinical placements. With the emergence of new pharmacotherapies (principally buprenorphine and naltrexone), training has been extended to encompass them. THE CURRENT PROJECT Outline This project is being conducted over four jurisdictions - South Australia, Queensland, New South Wales and Victoria. It is known anecdotally that many trained GPs do not become methadone prescribers. Not only is this a waste of training resources, but there is a shortfall in opioid treatment places. As such, there is an urgent need for trained prescribers willing to engage with these clients. Nationally, it is estimated that in 1997/98 there were 74,000 dependent heroin users in Australia (Law, Lynskey, Ross and Hall, 2001) and 24,657 clients in methadone treatment (Australian Institute of Health and Welfare, 1998). It is self evident that not all heroin dependent people are seeking treatment generally or methadone treatment specifically. However, there is an acknowledged shortfall, typified by the South Australian experience, with an estimated deficit of 500 places (personal communication Warinilla clinicians, November 2001). The research project encompasses three phases. The first two have already been implemented. 1. Determine Training Provision This phase examined the methods of recruitment of GPs into training. Data was collected from training providers and includes the number of training events held and the number of GPs who completed training at each event. 2. Determine Prescribing Activity 94

LIBBY HOTHAM, ANN M ROCHE, EMMA FITZGERALD The second phase focused on the prescribing activity of trained GPs. In particular, whether trained GPs commenced prescribing to opioid dependent clients soon after training and if they continued to prescribe for an extended period. This data was collected from the state government departments responsible for overseeing GP provision of pharmacotherapies. 3. GP Interviews Telephone interviews will be conducted with GPs at each step in the training and prescribing cycle to determine factors that influence: interest in training commencement of prescribing continued prescribing. Project Progress In late 2001 and early 2002, preliminary telephone contact was established with key people in the four jurisdictions under consideration. These included: state government departments of Health in relation to prescribing records training providers in relation to data held on training events over the last few years medical registration boards and the Royal Australian College of General Practitioners. 3 Formal questionnaires were developed for GP interviewing and an application for ethics approval was made to the Social and Behavioural Research Ethics Committee of Flinders University. Training: Data to Date Data were collected for the period 1999-2001. In South Australia, 50 GPs completed methadone training in this period. Many of these have not commenced prescribing. A further 35 GPs, at least, commenced training but did not complete it. In Queensland, 68 GPs completed methadone training. The training provider has not established a process to determine how many of those trained begin prescribing. Prescribing: Data to Date As of May 2002, prescribing data had been collected for South Australia, Queensland and Victoria. The method of collating prescribing information was unique in each jurisdiction and the data are not directly comparable. In addition, the South Australian data are much more detailed because extra departmental analysis was specifically undertaken for this project. It is therefore possible to draw conclusions from the South Australian data that is not currently possible for the other jurisdictions. South Australia The South Australian Department of Human Services provided de-identified demographic data for each GP prescribing in that state, including age, gender, years qualified, years authorised as a methadone prescriber, practice(s) location and number of practice partners. The relationship between prescribing activity (number of current clients) and the age of the GP is shown in Figure 1. 95

Outcomes of Training General Practitioners to Prescribe Methadone 800 Current number of methadone clients 600 400 200 0 25-34 35-44 45-54 55-64 65+ Prescriber age (years) Figure 1: South Australian GP Methadone Clients by Prescriber Age Table 1 shows the number of active prescribers and the average number of clients for each GP in a specified age category. Table 1: Average Number of Clients Per South Australian GP in Specified Age Category GP Age (years) Number of Active Prescribers Average Number of Clients per GP 25-34 5 14 35-44 13 18 45-54 14 25 55-64 16 47 65+ 2 55 The data indicate that in this jurisdiction the majority of methadone clients are being cared for by practitioners aged 55 years or over. Queensland Although no demographic data were available, information supplied indicated that, unlike South Australia, GPs care for a small proportion of methadone clients throughout the state, the majority being treated in public clinics. The current 46 active GP prescribers in Queensland account for less than 10% of clients. In South Australia, in contrast, 52 GPs treat almost 60% of methadone clients. Victoria Prescribing data in Victoria are kept in a different format, making comparison with data from other jurisdictions difficult. Again, no demographic data has been supplied. The most pertinent information to be gained at this time is the classification of doctors and clients according to the doctor s methadone client load. However, departmental data does not formally distinguish between GPs and other doctors with methadone clients. In addition, some doctors practice at more than one location and the actual number of methadone prescribers can only be extracted manually from the database. The database indicates 431 authorised methadone prescribers in Victoria. However, when manual adjustment has been made for duplicate 96

LIBBY HOTHAM, ANN M ROCHE, EMMA FITZGERALD addresses, there are only 383 doctors prescribing methadone, of whom 331 are GPs. Figure 2 shows an analysis of data for the database and is derived from numbers not adjusted for duplication. 300 250 Number of GPs 200 150 100 50 0 <10 10 to 29 30 to 49 50 to 99 100+ Methadone client load (number of methadone clients) Figure 2: Number of Victorian Methadone Prescribers by Methadone Client Load Further data giving the number of clients for each prescribing doctor does not distinguish between methadone clients and those on buprenorphine. Table 2 demonstrates that the majority of pharmacotherapy clients are being treated by doctors who have a large number of such clients in their practice. Given earlier data related to methadone providers (see Figure 2) it appears that the majority of pharmacotherapy clients are being cared for by a disproportionately limited number of doctors. 3 Table 2: Number of Methadone and Buprenorphine Clients (Victoria) by Client Load Prescriber Client Load (number of pharmacotherapy clients) Number of Pharmacotherapy Clients Percentage of Total Pharmacotherapy Clients <10 664 6.7 10 to 29 1,661 16.9 30 to 49 695 7.1 50 to 99 1,695 17.2 100+ 5,141 52.2 Future Directions Data collection continues across the four jurisdictions. The major obstacle is inconsistency between jurisdictions in the method of data collection and the scope of available data. This makes relevant comparisons difficult. At this stage, it has been determined that in both South Australia and Victoria the majority of methadone clients are being cared for by a disproportionately small number of doctors. This may have serious repercussions if any of these practitioners discontinue practice. The South Australian data indicates that this could occur in the short term, given the age of some of the GPs heavily involved in methadone prescribing. No similar analysis can be conducted with the other jurisdictions given the absence of demographic details. 97

Outcomes of Training General Practitioners to Prescribe Methadone The next phase of this project involves personal telephone interviews with GPs regarding each step of the training and prescribing cycle. ACKNOWLEDGEMENTS The researchers would like to acknowledge the contribution of Dr Ann Deehan to earlier stages of this project. They would also like to thank: Mr Geoff Anderson and Dr Paul Williamson (South Australia) Ms Janet Morey (Victoria) Mr Bill Parlet and Dr Alun Richards (Queensland). REFERENCES Allsop, S., Bell, J., Brough, R., Dwyer, P., Edmonds, C., Lintzeris, N., Mohindra, V. (1997) Learning objectives for methadone prescribers. Canberra: Commonwealth Department of Health and Family Services. Australian Institute of Health and Welfare (1998) Chapter 9, Treatment Services. Available at: <http://www.aihw.gov.au/publications/health/ sdua98/sdua98-c09.pdf> [Accessed 24 April 2002] Bell, A. (2002) Drug scourge whipped. Herald Sun, 4 April 2002. Dole, P., Nyswander, M. (1965) A Medical Treatment for Diacetylmorphine (Heroin) Addiction. Journal of the American Medical Association, 193(2):646-650. Fiellin, D.A., O Connor, P.G., Chawarski, M., Pakes, J.P., Pantalon, M.V., Schottenfeld, R.S. (2001) Methadone Maintenance in Primary Care - A Randomised Controlled Trial. Journal of the American Medical Association, 286(14):1724-1731. Glanz, A. (1993) The Role of General Practitioners in the Treatment of Drug Misuse, with Particular Emphasis on the Problem of HIV Transmission. PhD Thesis, University of London, London. Humeniuk, R., Ali, R., White, J., Hall, W., Farrell, M. (2000) Proceedings of Expert Workshop in the Induction and Stabilisation onto Methadone (Monograph 39). Adelaide: Commonwealth Department of Health and Ageing. Law, M.G., Lynskey, M., Ross, J., Hall, W. (2001) Back-projection estimates of the number of dependent heroin users in Australia. Addiction, 96:433-443. Mattick, R.P., Ali, R., Diguisto, E., Bammer, G., et al (2001) National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Sydney: National Drug and Alcohol Research Centre. Watters, B. (1999) Prevention, Demand Reduction and Treatment: a way forward for Australia, Heroin crisis: key commentators discuss the issues and debate solutions to heroin abuse in Australia (pp. 33-45). Melbourne: Brookman Press. Wodak, A., Bell, J. (1996) Methadone overdose in Australia. Alcohol and Drug Services, St Vincent s Hospital. Available from: <http://www.q4q.nl.methwork/newsletter9/ australia.htm [Accessed 11 June 2002]. Author Contact Details Ms Libby Hotham Lecturer National Centre for Education and Training on Addiction (NCETA) Flinders University GPO Box 2100 Adelaide SA 5001 Ph: 08 8201 7565 libby.hotham@flinders.edu.au 98